Duloxetine Active Pharmaceutical Ingredients (API) Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Duloxetine Active Pharmaceutical Ingredients (API), and Geography

Report Code: TIPRE00016855 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Duloxetine is a selective inhibitor of serotonin and norepinephrine reuptake which is widely used for neuropathic pain and as an antidepressant. Duloxetine treatment can be associated with asymptomatic intermittent elevations in serum aminotransferase levels and has been associated with unusual cases of clinically evident acute liver injury. Duloxetine is a potent serotonin and norepinephrine reuptake inhibitor that is commonly used both as an antidepressant and for neuropathic pain. Treatment with duloxetine can be associated with asymptomatic transient serum aminotransferase elevations and has been associated with rare cases of clinically noticeable acute liver injury.

MARKET DYNAMICS

Factors driving the growth of the duloxetine active pharmaceutical ingredients (API) market are the growing prevalence of depression, coupled with rising anxiety disorders. However, the side-effects of duloxetine active pharmaceutical ingredients (API) and is expected to hamper the growth of the market. Moreover, increasing penetration of generic drugs and rising trend of outsourcing, strong drug pipeline among others is anticipated to boost the market growth.

MARKET SCOPE

The "Duloxetine Active Pharmaceutical Ingredients (API) Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of duloxetine active pharmaceutical ingredients (API) market with detailed market segmentation by application. The duloxetine active pharmaceutical ingredients (API) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in duloxetine active pharmaceutical ingredients (API) market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The duloxetine active pharmaceutical ingredients (API) market is segmented on the basis of application. Based on application, the market is segmented as major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain, chronic musculoskeletal pain, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the duloxetine active pharmaceutical ingredients (API) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The duloxetine active pharmaceutical ingredients (API) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting duloxetine active pharmaceutical ingredients (API) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the duloxetine active pharmaceutical ingredients (API) market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the duloxetine active pharmaceutical ingredients (API) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from duloxetine active pharmaceutical ingredients (API) market are anticipated to have lucrative growth opportunities in the future with the rising demand for duloxetine active pharmaceutical ingredients (API) in the global market. Below mentioned is the list of few companies engaged in the duloxetine active pharmaceutical ingredients (API) market.

The report also includes the profiles of key players in duloxetine active pharmaceutical ingredients (API) market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Teva Pharmaceutical Industries Ltd
  •  Sun Pharmaceutical Industries Ltd
  •  Aurobindo Pharma
  •  Lupin
  •  Zydus Cadila
  •  Eli Lilly and Company
  •  Hetero
  •  Apotex Inc.
  •  Shionogi Inc.
  •  Zhejiang Huahai Pharmaceutical Co., Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Duloxetine Active Pharmaceutical Ingredients (API) Market - By Application
1.3.2 Duloxetine Active Pharmaceutical Ingredients (API) Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET - GLOBAL MARKET ANALYSIS
6.1. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) - GLOBAL MARKET OVERVIEW
6.2. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. MAJOR DEPRESSIVE DISORDER
7.3.1. Overview
7.3.2. Major Depressive Disorder Market Forecast and Analysis
7.4. GENERALIZED ANXIETY DISORDER
7.4.1. Overview
7.4.2. Generalized Anxiety Disorder Market Forecast and Analysis
7.5. FIBROMYALGIA
7.5.1. Overview
7.5.2. Fibromyalgia Market Forecast and Analysis
7.6. NEUROPATHIC PAIN. CHRONIC MUSCULOSKELETAL PAIN OTHERS
7.6.1. Overview
7.6.2. Neuropathic Pain. Chronic Musculoskeletal Pain Others Market Forecast and Analysis
8. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Overview
8.1.2 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis
8.1.3 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Application
8.1.4 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Countries
8.1.4.1 United States Duloxetine Active Pharmaceutical Ingredients (API) Market
8.1.4.1.1 United States Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.1.4.2 Canada Duloxetine Active Pharmaceutical Ingredients (API) Market
8.1.4.2.1 Canada Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.1.4.3 Mexico Duloxetine Active Pharmaceutical Ingredients (API) Market
8.1.4.3.1 Mexico Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.2. EUROPE
8.2.1 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Overview
8.2.2 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis
8.2.3 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Application
8.2.4 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Duloxetine Active Pharmaceutical Ingredients (API) Market
8.2.4.1.1 Germany Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.2.4.2 France Duloxetine Active Pharmaceutical Ingredients (API) Market
8.2.4.2.1 France Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.2.4.3 Italy Duloxetine Active Pharmaceutical Ingredients (API) Market
8.2.4.3.1 Italy Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.2.4.4 Spain Duloxetine Active Pharmaceutical Ingredients (API) Market
8.2.4.4.1 Spain Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.2.4.5 United Kingdom Duloxetine Active Pharmaceutical Ingredients (API) Market
8.2.4.5.1 United Kingdom Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.2.4.6 Rest of Europe Duloxetine Active Pharmaceutical Ingredients (API) Market
8.2.4.6.1 Rest of Europe Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Overview
8.3.2 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis
8.3.3 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Application
8.3.4 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Duloxetine Active Pharmaceutical Ingredients (API) Market
8.3.4.1.1 Australia Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.3.4.2 China Duloxetine Active Pharmaceutical Ingredients (API) Market
8.3.4.2.1 China Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.3.4.3 India Duloxetine Active Pharmaceutical Ingredients (API) Market
8.3.4.3.1 India Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.3.4.4 Japan Duloxetine Active Pharmaceutical Ingredients (API) Market
8.3.4.4.1 Japan Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.3.4.5 South Korea Duloxetine Active Pharmaceutical Ingredients (API) Market
8.3.4.5.1 South Korea Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.3.4.6 Rest of Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market
8.3.4.6.1 Rest of Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Overview
8.4.2 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis
8.4.3 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Application
8.4.4 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Duloxetine Active Pharmaceutical Ingredients (API) Market
8.4.4.1.1 South Africa Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.4.4.2 Saudi Arabia Duloxetine Active Pharmaceutical Ingredients (API) Market
8.4.4.2.1 Saudi Arabia Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.4.4.3 U.A.E Duloxetine Active Pharmaceutical Ingredients (API) Market
8.4.4.3.1 U.A.E Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.4.4.4 Rest of Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market
8.4.4.4.1 Rest of Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Duloxetine Active Pharmaceutical Ingredients (API) Market Overview
8.5.2 South and Central America Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis
8.5.3 South and Central America Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Application
8.5.4 South and Central America Duloxetine Active Pharmaceutical Ingredients (API) Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Duloxetine Active Pharmaceutical Ingredients (API) Market
8.5.4.1.1 Brazil Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.5.4.2 Argentina Duloxetine Active Pharmaceutical Ingredients (API) Market
8.5.4.2.1 Argentina Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
8.5.4.3 Rest of South and Central America Duloxetine Active Pharmaceutical Ingredients (API) Market
8.5.4.3.1 Rest of South and Central America Duloxetine Active Pharmaceutical Ingredients (API) Market by Application
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DULOXETINE ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, KEY COMPANY PROFILES
11.1. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SUN PHARMACEUTICAL INDUSTRIES LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. AUROBINDO PHARMA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LUPIN
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ZYDUS CADILA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HETERO
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. APOTEX INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SHIONOGI INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd
2. Sun Pharmaceutical Industries Ltd
3. Aurobindo Pharma
4. Lupin
5. Zydus Cadila
6. Eli Lilly and Company
7. Hetero
8. Apotex Inc.
9. Shionogi Inc.
10. Zhejiang Huahai Pharmaceutical Co., Ltd
TIPRE00016855
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking